HIV prevention before HAART in sub-Saharan Africa.

摘要: Summary Data on the cost-effectiveness of HIV prevention in sub-Saharan Africa and highly active antiretroviral therapy (HAART) indicate that is at least 28 times more cost effective than HAART. We aim to show funding HAART expense means greater loss life. To maximise health benefits, next major increments should be devoted mainly some non-HAART treatment care. Funds allocated primarily for demonstration projects will help prepare scaled-up provision following broad population coverage by programmes. UNAIDS London School Hygiene Tropical Medicine recently estimated US$9·2 billion annually required mount an appropriate response pandemic, including substantial date, US$1·96 has been committed newly-established UN Global Fund Fight AIDS, Tuberculosis, Malaria. It a moral imperative expanded programmes control implemented without delay, goal or annual spending attained as rapidly possible. The findings recommendations this analysis pertain phasing additional HIV-related activities during current period improved but inadequate funding.